Azenta to sell B Medical Systems unit for $63 million

Azenta (NASDAQ:AZTA) has signed a binding agreement to sell its B Medical Systems business to THELEMA S.À R.L. for $63 million, as the company moves to streamline operations and focus on its core capabilities.

The company said the transaction is expected to close on or before March 31, 2026, subject to customary closing conditions.

Azenta said the divestiture is intended to simplify its portfolio and allow management to prioritize areas aligned with its long-term strategy.

Proceeds from the sale will be used to strengthen the balance sheet and support initiatives aimed at creating long-term value for shareholders.

William Blair served as exclusive financial advisor to Azenta on the transaction, while Taylor Wessing acted as legal counsel.